Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)

Clinical trial NCT06980389 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06980389
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immune Checkpoint Therapy Radiotherapy Metastatic Gastric Carcinoma

Start date: 2025-05-31
Primary completion: 2027-12-31
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.